FATE THERAPEUTICS INC (FATE) Stock Analyst Ratings
NASDAQ:FATE - Nasdaq - US31189P1021 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 75% to FATE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 6.52. This target is 397.46% above the current price.
FATE was analyzed by 19 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about FATE.
In the previous month the buy percentage consensus was at a similar level.
FATE was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-06 | Needham | Reiterate | Hold -> Hold |
| 2025-03-06 | Stifel | Maintains | Hold -> Hold |
| 2025-03-06 | Wedbush | Reiterate | Neutral -> Neutral |
| 2025-03-06 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-19 | Needham | Reiterate | Hold |
| 2024-11-13 | Needham | Reiterate | Hold |
| 2024-08-22 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-08-14 | Needham | Reiterate | Hold |
| 2024-06-17 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2024-05-16 | HC Wainwright & Co. | Maintains | Neutral -> Neutral |
| 2024-05-10 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-05-10 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-05-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-10 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2024-05-06 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-04-23 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-04-11 | Needham | Reiterate | Hold |
| 2024-03-28 | B of A Securities | Maintains | Underperform -> Underperform |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Neutral |
| 2024-02-27 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2024-02-27 | Oppenheimer | Reiterate | Perform -> Perform |
| 2024-02-27 | Barclays | Maintains | Overweight -> Overweight |
| 2024-02-27 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-02-27 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-20 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-11-09 | BMO Capital | Maintains | Market Perform -> Market Perform |
| 2023-11-09 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-11-09 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |